US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist
  • 12.940
  • +0.640+5.20%
Close May 24 16:00 ET
  • 12.940
  • 0.0000.00%
Post 16:01 ET
236.41MMarket Cap-12442P/E (TTM)

OptimizeRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OptimizeRx Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

19.69M

+51.43%
EPS(YoY)

-0.38

-2.70%
Analyst Rating

Strong Buy

May 15, 2024

OptimizeRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 25.525M--
--2024/Q2-- / 20.593M--
May 14, 20242024/Q119.690M / 18.132M--
Mar 28, 20242023/Q428.369M / 26.946M--
Nov 6, 20232023/Q316.331M / 15.138M--
Aug 14, 20232023/Q213.818M / 14.807M--
May 10, 20232023/Q113.003M / 12.355M--
Mar 8, 20232022/Q419.700M / 21.768M--
Nov 8, 20222022/Q315.086M / 15.016M--
Aug 9, 20222022/Q213.979M / 17.065M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 25.525M--
--2024/Q2-- / 20.593M--
May 14, 20242024/Q119.690M / 18.132M--
Mar 28, 20242023/Q428.369M / 26.946M--
Nov 6, 20232023/Q316.331M / 15.138M--
Aug 14, 20232023/Q213.818M / 14.807M--
May 10, 20232023/Q113.003M / 12.355M--
Mar 8, 20232022/Q419.700M / 21.768M--
Nov 8, 20222022/Q315.086M / 15.016M--
Aug 9, 20222022/Q213.979M / 17.065M--

Unlock Free Earnings Estimates

OptimizeRx Earnings Reports

  • OptimizeRx | 10-Q: Quarterly report

    May 15 17:08 ET

  • OptimizeRx | 10-K: Annual report

    Apr 15 16:45 ET

  • OptimizeRx: Q3 2023 Earnings Report

    Nov 14, 2023 16:00 ET

  • OptimizeRx | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 15, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg